Skip to main content

Advertisement

Log in

Is anti-seizure medication the culprit of SUDEP?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Heart rate variability (HRV) reduction is a potential biomarker for sudden cardiac death. This study aimed to study the effects of anti-seizure medications (ASMs), adjusted with reported factors associated with sudden unexpected death in epilepsy (SUDEP) on HRV parameters.

Methods

We recruited patients who were admitted in our epilepsy monitoring unit between January 2013 and December 2021. Two 5-min electrocardiogram epochs during wakefulness and sleep were selected in each patient. HRV analysis with Python® software was performed. The imputed datasets were used for linear regression analysis to assess association between each ASM item and all HRV parameters. The effects of ASM on HRV parameters were subsequently adjusted with the significant clinical characteristics and the concomitant use of other ASMs, respectively.

Results

Carbamazepine (CBZ), levetiracetam (LEV), lamotrigine (LTG), and clonazepam (CZP) were statistically significantly associated with changes of sleep HRV parameters. Only CBZ showed negative effects with reduction in HRV, evidenced as lower standard deviation of RR interval (SDNN), even when adjusted with concomitant use of other ASMs (p = 0.045) and had a trend of significance when adjusted with significant clinical characteristics of concurrent taking of beta-blocker drug (p = 0.052). LEV and CZP showed opposite effects with increased HRV even when adjusted with significant clinical characteristics and the concomitant use of other ASMs.

Conclusions

CBZ showed negative effects on HRV. We proposed that CBZ should be cautiously used in patients with known risks for SUDEP. In addition, HRV assessment should be performed prior to commencing CBZ and re-performed in follow-up in cases of prolonged use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Ansakorpi H, Korpelainen JT, Suominen K, Tolonen U, Myllylä VV, Isojärvi JI (2000) Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy. Epilepsia 41(1):42–47. https://doi.org/10.1111/j.1528-1157.2000.tb01503.x

    Article  CAS  PubMed  Google Scholar 

  2. Aurlien D, Taubøll E, Gjerstad L (2007) Lamotrigine in idiopathic epilepsy - increased risk of cardiac death? Acta Neurol Scand 115(3):199–203. https://doi.org/10.1111/j.1600-0404.2006.00730.x

    Article  CAS  PubMed  Google Scholar 

  3. Clancy MJ, Clarke MC, Connor DJ, Cannon M, Cotter DR (2014) The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry 14:75. https://doi.org/10.1186/1471-244x-14-75

    Article  PubMed  PubMed Central  Google Scholar 

  4. DeGiorgio CM, Curtis A, Hertling D, Moseley BD (2019) Sudden unexpected death in epilepsy: risk factors, biomarkers, and prevention. Acta Neurol Scand 139(3):220–230. https://doi.org/10.1111/ane.13049

    Article  PubMed  Google Scholar 

  5. Druschky A, Hilz MJ, Hopp P, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, Stefan H, Neundörfer B (2001) Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [(123)I]metaiodobenzylguanidine-SPECT. Brain 124(Pt 12):2372–2382. https://doi.org/10.1093/brain/124.12.2372

    Article  CAS  PubMed  Google Scholar 

  6. Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jetté N (2017) Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88(3):296–303. https://doi.org/10.1212/wnl.0000000000003509

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gaitatzis A, Carroll K, Majeed A, Sander JW (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45(12):1613–1622. https://doi.org/10.1111/j.0013-9580.2004.17504.x

    Article  PubMed  Google Scholar 

  8. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459–480

  9. Graham JW (2009) Missing data analysis: making it work in the real world. Annu Rev Psychol 60:549–576. https://doi.org/10.1146/annurev.psych.58.110405.085530

    Article  PubMed  Google Scholar 

  10. Graham JW, Olchowski AE, Gilreath TD (2007) How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 8(3):206–213. https://doi.org/10.1007/s11121-007-0070-9

    Article  PubMed  Google Scholar 

  11. Hallioglu O, Okuyaz C, Mert E, Makharoblidze K (2008) Effects of antiepileptic drug therapy on heart rate variability in children with epilepsy. Epilepsy Res 79(1):49–54. https://doi.org/10.1016/j.eplepsyres.2007.12.020

    Article  CAS  PubMed  Google Scholar 

  12. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354–81

  13. Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser A (2011) Combined analysis of risk factors for SUDEP. Epilepsia 52(6):1150–1159. https://doi.org/10.1111/j.1528-1167.2010.02952.x

    Article  PubMed  Google Scholar 

  14. Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser WA (2012) Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 53(2):249–252. https://doi.org/10.1111/j.1528-1167.2011.03354.x

    Article  PubMed  Google Scholar 

  15. Isojärvi JI, Ansakorpi H, Suominen K, Tolonen U, Repo M, Myllylä VV (1998) Interictal cardiovascular autonomic responses in patients with epilepsy. Epilepsia 39(4):420–426. https://doi.org/10.1111/j.1528-1157.1998.tb01394.x

    Article  PubMed  Google Scholar 

  16. Jain S, Nair PP, Aghoram R, Wadwekar V, Wagh S, Balachandran M, Indira Priya D, Meher R, Nandwani S, Sreekumaran Nair N (2021) Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: a cross-sectional study. Epilepsy Behav 125:108396. https://doi.org/10.1016/j.yebeh.2021.108396

    Article  PubMed  Google Scholar 

  17. Jiang W, Ladd S, Martsberger C, Feinglos M, Spratt SE, Kuchibhatla M, Green J, Krishnan R (2011) Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. J Clin Psychopharmacol 31(2):207–213. https://doi.org/10.1097/JCP.0b013e31820f4f57

    Article  CAS  PubMed  Google Scholar 

  18. Keezer MR, Sisodiya SM, Sander JW (2016) Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol 15(1):106–115. https://doi.org/10.1016/s1474-4422(15)00225-2

    Article  PubMed  Google Scholar 

  19. Kennebäck G, Ericson M, Tomson T, Bergfeldt L (1997) Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death. Seizure 6(5):369–375. https://doi.org/10.1016/s1059-1311(97)80036-2

    Article  PubMed  Google Scholar 

  20. Lathers CM, Schraeder PL (1982) Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity. Epilepsia 23(6):633–647. https://doi.org/10.1111/j.1528-1157.1982.tb05079.x

    Article  CAS  PubMed  Google Scholar 

  21. Levira F, Thurman DJ, Sander JW, Hauser WA, Hesdorffer DC, Masanja H, Odermatt P, Logroscino G, Newton CR (2017) Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 58(1):6–16. https://doi.org/10.1111/epi.13603

    Article  PubMed  Google Scholar 

  22. Lotufo PA, Valiengo L, Benseñor IM, Brunoni AR (2012) A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs. Epilepsia 53(2):272–282. https://doi.org/10.1111/j.1528-1167.2011.03361.x

    Article  PubMed  Google Scholar 

  23. Moss G, Stein AA (1975) Cerebral etiology of the acute respiratory distress syndrome: diphenylhydantoin prophylaxis. J Trauma 15(1):39–41. https://doi.org/10.1097/00005373-197501000-00007

    Article  CAS  PubMed  Google Scholar 

  24. Myers KA, Sivathamboo S, Perucca P (2018) Heart rate variability measurement in epilepsy: how can we move from research to clinical practice? Epilepsia 59(12):2169–2178. https://doi.org/10.1111/epi.14587

    Article  PubMed  Google Scholar 

  25. Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tomson T (1999) Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353(9156):888–893. https://doi.org/10.1016/s0140-6736(98)05114-9

    Article  CAS  PubMed  Google Scholar 

  26. Persson H, Ericson M, Tomson T (2003) Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy. Epilepsy Res 57(1):69–75. https://doi.org/10.1016/j.eplepsyres.2003.10.012

    Article  CAS  PubMed  Google Scholar 

  27. Sathyaprabha TN, Koot LAM, Hermans BHM, Adoor M, Sinha S, Kramer BW, Raju TR, Satishchandra P, Delhaas T (2018) Effects of chronic carbamazepine treatment on the ECG in patients with focal seizures. Clin Drug Investig 38(9):845–851. https://doi.org/10.1007/s40261-018-0677-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8(1):3–15. https://doi.org/10.1177/096228029900800102

    Article  CAS  PubMed  Google Scholar 

  29. Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, Ruberto M, Biondi A, Cascio O, Bertozzi G, Pisanelli D, Maglietta F, Messina A, Mollica MP, Salerno M (2018) Heart rate variability as predictive factor for sudden cardiac death. Aging (Albany NY) 10(2):166–177. https://doi.org/10.18632/aging.101386

    Article  PubMed  Google Scholar 

  30. Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Frontiers in Public Health 5:258. https://doi.org/10.3389/fpubh.2017.00258

  31. Shankar R, Donner EJ, McLean B, Nashef L, Tomson T (2017) Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know. Epileptic Disord 19(1):1–9. https://doi.org/10.1684/epd.2017.0891

    Article  PubMed  Google Scholar 

  32. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Bmj 338:b2393. https://doi.org/10.1136/bmj.b2393

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sveinsson O, Andersson T, Carlsson S, Tomson T (2017) The incidence of SUDEP: a nationwide population-based cohort study. Neurology 89(2):170–177. https://doi.org/10.1212/wnl.0000000000004094

    Article  PubMed  Google Scholar 

  34. Téllez-Zenteno JF, Matijevic S, Wiebe S (2005) Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 46(12):1955–1962. https://doi.org/10.1111/j.1528-1167.2005.00344.x

    Article  PubMed  Google Scholar 

  35. Thurman DJ, Logroscino G, Beghi E, Hauser WA, Hesdorffer DC, Newton CR, Scorza FA, Sander JW, Tomson T (2017) The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 58(1):17–26. https://doi.org/10.1111/epi.13604

    Article  PubMed  Google Scholar 

  36. Timmings PL (1998) Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure 7(4):289–291. https://doi.org/10.1016/s1059-1311(98)80020-4

    Article  CAS  PubMed  Google Scholar 

  37. Tomson T, Kennebäck G (1997) Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 38(11 Suppl):S48-51. https://doi.org/10.1111/j.1528-1157.1997.tb06128.x

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Veera Saidoung for helping with HRV analysis and EEG database management.

Author information

Authors and Affiliations

Authors

Contributions

Danist Leosuthamas: Carried out data acquisition, drafted the manuscript, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Chusak Limotai: Designed the study, carried out data acquisition and data analysis, drafted the manuscript, critically revised the manuscript, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Nattawut Unwanatham: Carried out data analysis, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy. Sasivimol Rattanasiri: Carried out data analysis, gave final approval, and agreed to be accountable for all aspects of work ensuring integrity and accuracy.

Corresponding author

Correspondence to Chusak Limotai.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

The study was approved by the Institutional Review Board of Faculty of Medicine, Chulalongkorn University. 

Informed consent

Informed consent was waived because of the retrospective nature of the study and the analysis used anonymous clinical data.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Highlights

• Reductions in HRV were found in epilepsy subgroups at high risk for SUDEP, i.e., chronic TLE and Dravet’s syndrome.

• Controversy still surrounds whether or not ASMs are related to SUDEP.

• In our study population, i.e., drug-resistant focal epilepsy mainly TLE, negative effect of CBZ, and reduction in HRV was demonstrated.

• CBZ should be cautiously used in patients with known risks for SUDEP.

• HRV assessment should be performed prior to commencing CBZ and re-performed in follow-up in cases of prolonged use.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leosuthamas, D., Limotai, C., Unwanatham, N. et al. Is anti-seizure medication the culprit of SUDEP?. Neurol Sci 44, 3659–3668 (2023). https://doi.org/10.1007/s10072-023-06871-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06871-0

Keywords

Navigation